The CD79a Monoclonal Antibody [Clone IGA/764] is a highly specific mouse monoclonal antibody that targets CD79a, a crucial signaling molecule of the B-cell receptor complex. CD79a is expressed early in B-cell development and continues through to the plasma cell stage, making it an essential marker for identifying B-cell lineage in both reactive and neoplastic conditions. Clone IGA/764 delivers robust membranous and cytoplasmic staining in B lymphocytes and B-cell derived malignancies, making it a valuable tool for diagnostic immunohistochemistry.
Mouse
Recombinant human IGA protein
IGA/764
IgG1, kappa
Human. Others not known.
Daudi or Ramos cells. Germinal center B-cells in a lymph node or tonsil.
Anti-CD79a is generally used to complement anti-CD20 especially for mature B-cell lymphomas after treatment with Rituximab (anti-CD20).
Cell surface